UNIQA Insurance Group AG/ AT0000821103 /
21.05.2024 11:15:37 | Изменение - | Объем сделки | Бид9:00:08 | Предложение9:00:08 | Рыночная капитализация | Дивидендная доходность | Коэффициент Цена/Доход |
---|---|---|---|---|---|---|---|
8.29EUR | - | 313 Оборот: 2,593.21 |
-Величина цены спроса: - | -Величина цены предложения: - | 2.53 млрдEUR | 6.93% | 8.31 |
GlobeNewswire
16:03
Zealand Pharma announces positive CHMP opinion for dasiglucagon for treatment of severe hypoglycemia...
Newsfile Corp
16:00
Wiz Slots Launches in Canada, Bringing Unique Entertainment Experience to Canadian Gamers
GlobeNewswire
16:00
Concurrent Technologies Corporation Awarded $7.2 Million Contract Modification for Air Force Environ...
GlobeNewswire
16:00
MCICOM Awards Concurrent Technologies Corporation $37M Contract to Build on Efforts to Improve Marin...
GlobeNewswire
16:00
CertiK Announces the Launch of CertiK Ventures to Shape the Future of Onchain Innovation
GlobeNewswire
16:00
Mountain America Credit Union’s Christine Ebert Recognized Among Utah Business 30 Women to Watch
GlobeNewswire
16:00
RegEd’s AI-Powered Advertising Review Solution Surpasses 350,000 Users, Solidifying its Position as ...
GlobeNewswire
16:00
Concurrent Technologies Corporation to Continue Efforts to Improve Marine Corps Energy Resiliency
GlobeNewswire
16:00
Concurrent Technologies Corporation Aims to Reduce Army Combat Vehicle Weight and Improve Survivabil...
GlobeNewswire
15:58
Ferrellgas and Blue Rhino Encourage Customers to be Prepared for Hurricane Season
Newsfile Corp
15:40
SEC Investor Advisory Committee to Examine the New Frontier for Investment Advice and Discuss AI Reg...
GlobeNewswire
15:36
Direct Digital Holdings Sued for Securities Violations by Block & Leviton; Investors Who Have Lost M...
GlobeNewswire
15:30
fullthrottle.ai Releases Audience Planner Fueled by Generative AI to Simplify Addressable Targeting ...
GlobeNewswire
15:29
Medicenna To Present Evidence of Durable Single Agent Activity and Potent Immune Effector Response w...
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница